Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant.
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2016
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 05 Feb 2016 Planned End Date changed from 1 Dec 2014 to 1 Dec 2017 as per ClinicalTrials.gov record.
- 27 Dec 2010 New trial record